Healthcare - Biotechnology - NASDAQ - US
$ 0.6202
3.37 %
$ 3.13 M
Market Cap
-0.17
P/E
INCOME STATEMENT
0
REVENUE
-9.38 M
OPERATING INCOME
-8.69 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Quoin Pharmaceuticals, Ltd.
| Revenue | 0 |
| Cost Of Revenue | 103 K |
| Gross Profit | -103 K |
| Operating Expenses | 9.38 M |
| Operating Income | -9.38 M |
| Other Expenses | -692 K |
| Net Income | -8.69 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | (0.3) | 0 | (0.3) | 0 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 89.1 K | 18.3 K |
| Gross Profit | (0.1) | (0.1) | (0.1) | (0.1) | (0.2) | (0.4) | (0.1) | (0.4) | 18.3 K |
| OPERATING INCOME | |||||||||
| Operating Expenses | 9.4 | 9.3 | 6.1 | 1.7 | 1.6 | 16.2 | 10.1 | 16.2 | 2.6 |
| Selling, General and Administrative Expenses | 6.1 | 6.6 | 4.5 | 1.4 | 1.5 | 8.0 | 4.2 | 8.0 | 1.1 |
| Research and Development Expenses | 3.3 | 2.7 | 1.6 | 0.2 | 45.6 K | 8.3 | 5.9 | 8.3 | 1.5 |
| Operating Income | (9.4) | (8.8) | (20.4) | (2.0) | (1.6) | 15.3 | 10.2 | 15.3 | (2.6) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0 | 0.7 | 1.1 | 47 K | 0.4 | 0 | 0 | 0 | 0 |
| Total Other Income | 0.7 | (0.1) | (1.1) | (0.4) | 0 | 2.5 | (1.1) | 0.2 | 19.3 K |
| Pre-Tax Income | (8.7) | (9.4) | (21.5) | (2.1) | (1.6) | 15.3 | 10.2 | 15.3 | (2.6) |
| NET INCOME | |||||||||
| Tax Provision | 0 | (0.1) | (12.9) | (0.3) | 1.6 | (0.2) | (1.2) | 0.1 | 1 |
| Net Income | (8.7) | (9.3) | (8.5) | (1.8) | (1.6) | 15.3 | 10.2 | 15.3 | (2.6) |
| EPS | 9.64 | 23 | 322 | 88.1 | 440 | 7.1 K | 5.45 K | 10.1 K | 2.11 K |